Large-scale testing (Phase 3)Not Yet RecruitingNCT07597395What this trial is testingATRA for Management of Primary ITPWho this might be right forImmune Thrombocytopenia Peking University People's Hospital 192
Post-approval studies (Phase 4)Study completedNCT04089267What this trial is testingEvaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Patients With Primary Immune Thrombocytopenia (ITP)Who this might be right forITP Shenyang Sunshine Pharmaceutical Co., LTD. 288
Testing effectiveness (Phase 2)Looking for participantsNCT07234019What this trial is testingRituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)Who this might be right forImmune ThrombocytopeniaTreatment Institute of Hematology & Blood Diseases Hospital, China 160
Testing effectiveness (Phase 2)Looking for participantsNCT05995054What this trial is testingA Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune ThrombocytopeniaWho this might be right forImmune ThrombocytopeniaTreatment Institute of Hematology & Blood Diseases Hospital, China 110
Large-scale testing (Phase 3)Study completedNCT00157079What this trial is testingSafety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersWho this might be right forPrimary Immunodeficiency Diseases (PID)Immune Thrombocytopenic Purpura (ITP)Kawasaki Syndrome Baxalta now part of Shire 61
Post-approval studies (Phase 4)Study completedNCT03258866What this trial is testingThe Study of Different Dose Rituximab in the Treatment of ITPWho this might be right forPurpura, Thrombocytopenic, IdiopathicImmune Thrombocytopenia Shandong University 62
Large-scale testing (Phase 3)Study completedNCT03164915What this trial is testingA Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)Who this might be right forImmune Thrombocytopenia SK Plasma Co., Ltd. 37
Testing effectiveness (Phase 2)Looking for participantsNCT07362238What this trial is testingDaratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)Who this might be right forImmune ThrombocytopeniaTreatment Institute of Hematology & Blood Diseases Hospital, China 122
Early research (Phase 1)Not Yet RecruitingNCT07622329What this trial is testingA Clinical Study to Evaluate JCXH-213 in the Treatment of Adults With Primary Immune ThrombocytopeniaWho this might be right forThrombocytopenic Purpura, Immune The General Hospital of Western Theater Command 4
Testing effectiveness (Phase 2)UnknownNCT05943691What this trial is testingHigh-dose Dexamethasone Plus Hetrombopag vs High-dose Dexamethasone Alone as Frontline Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Prospective, Multicenter, Randomized TrialWho this might be right forITP - Immune Thrombocytopenia Shandong University 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023915What this trial is testingRandomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITPWho this might be right forImmune Thrombocytopenia Shandong University 106
Very early researchLooking for participantsNCT07441525What this trial is testingUCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological DiseasesWho this might be right forAutoimmune Hemolytic AnemiaPrimary Immune Thrombocytopenic PurpuraEvans Syndrome Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 27
Large-scale testing (Phase 3)Study completedNCT04687072What this trial is testingEvaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune ThrombocytopeniaWho this might be right forPrimary Immune Thrombocytopenia argenx 207
Testing effectiveness (Phase 2)Looking for participantsNCT06531018What this trial is testingRole of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.Who this might be right forPrimary Immune Thrombocytopenia Renata PLC 100
Large-scale testing (Phase 3)Study completedNCT05029635What this trial is testingPhase III Study on HMPL-523 for Treatment of ITPWho this might be right forPrimary Immune Thrombocytopenia (ITP) Hutchmed 272
Early research (Phase 1)WithdrawnNCT06291415What this trial is testingThe Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)Who this might be right forImmune ThrombocytopeniaBlood Platelet DisorderHematologic Diseases+14 more Hutchmed
Not applicableUnknownNCT06466824What this trial is testingObservational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010Who this might be right forPrimary Immune Thrombocytopenia Gruppo Italiano Malattie EMatologiche dell'Adulto 157
Testing effectiveness (Phase 2)Looking for participantsNCT06992128What this trial is testingRomiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional TrialWho this might be right forPrimary Immune Thrombocytopenia (ITP) Institute of Hematology & Blood Diseases Hospital, China 129
Very early researchUnknownNCT06417398What this trial is testingPreliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesWho this might be right forSystemic Lupus ErythematosusIdiopathic Inflammatory MyopathiesSystemic Sclerosis+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455006What this trial is testingSafety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric PatientsWho this might be right forThrombocytopenia, Immune Qilu Pharmaceutical Co., Ltd. 60